Ministry of Health and Family Welfare
Total recoveries leap up to 7.2 lakh
National Recovery Rate improves to 62.72%
Case Fatality continues to dip further to 2.43%
National Recovery Rate improves to 62.72%
Case Fatality continues to dip further to 2.43%
Posted On: 21 JUL 2020 7:41PM by PIB Delhi
Sustained, proactive, progressive and evidence-based
strategies for effective surveillance, testing through expanded effective
country-wide network of labs, coupled with Standard Treatment Protocol for
ensuring effective clinical treatment of COVID19 cases have resulted in a
progressive increase of 24,491 in COVID-19 recoveries during the last 24 hours.
This has pushed the cumulative figure of recovered cases among COVID-19
patients to 7,24,577, as on date.
The recovery rate has further improved to 62.72%.
This has also ensured that India continues to have one
of the lowest Case Fatality Rates, at 2.43%, which is consistently falling.
The gap between the number of recovered cases and active
cases has increased to 3,22,048 at present. Presently, there are 4,02,529
active cases and all are under medical supervision.
In the last 24 hours, 3,33,395 samples were tested.
Cumulatively 1,43,81,303 samples have been tested in the country. This has been
possible through ever expanding diagnostic lab network of 1274 labs, including
892 labs in the government sector and 382 private labs. These include:
•
Real-Time RT PCR based
testing labs: 651 (Govt: 398 + Private: 253)
• TrueNat based testing labs: 516 (Govt: 457 + Private: 59)
• CBNAAT based testing labs: 107 (Govt: 37 + Private: 70)
For all authentic & updated information on COVID-19
related technical issues, guidelines & advisories please regularly visit:
https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to COVID-19 may be sent to
technicalquery.covid19@gov.in and other queries on ncov2019@gov.in and
@CovidIndiaSeva .
In case of any queries on COVID-19, please call at the
Ministry of Health & Family Welfare helpline no.: +91-11-23978046 or 1075
(Toll-free). List of helpline numbers of States/UTs on COVID-19 is also
available at:
****
MV/SG
(Release ID: 1640254) Visitor Counter : 313
Ministry of Health and Family Welfare
19 State/UTs conducting more than 140 tests/day/million,
as advised by WHO
India currently has 8.07% Positivity Rate
30 State/UTs have lower Positivity Rate than India average
India currently has 8.07% Positivity Rate
30 State/UTs have lower Positivity Rate than India average
Posted On: 21 JUL 2020 7:38PM by PIB Delhi
The “Test, Track, Treat”
strategy encapsulates the holistic framework for management of COVID-19. Led by
the Centre, it has been implemented through various measures by the State/UT
governments. While States/UTs have substantially expanded their testing
network, they have also undertaken measures to facilitate widespread testing by
people at large. As a result the national average of tests/day/million has
substantially jumped to 180, as on date.
WHO in its Guidance Note on
“Public Health Criteria to Adjust Public Health and Social Measures in the
Context of COVID-19” has advised comprehensive surveillance for suspected
COVID19 cases. WHO has advised that a country needs 140 tests/day/ million
population.
There are currently 19 State/UTs
which are conducting more than 140 tests per day per million. The State of Goa
is testing highest at 1333 tests per day per million.
The Centre and ICMR have
continually advised the State/UT governments to improve the number of tests
conducted. Through the coordinated efforts, India’s testing per million (TPM)
has increased to 10421. This has helped in early detection and timely and
effective clinical management of COVID-19 cases.
In tandem with increased
testing, the Confirmation Rate or Positivity Rate for India is continuously
reducing and currently stands at 8.07%. There are 30 State/UTs in India which
have lower Positivity Rate than the India average. This indicates that
Centre-led initiative of increased testing is working in yielding positive
results.
For all authentic & updated
information on COVID-19 related technical issues, guidelines & advisories
please regularly visit: https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to
COVID-19 may be sent to technicalquery.covid19@gov.in and other queries on
ncov2019@gov.in and @CovidIndiaSeva .
In case of any queries on
COVID-19, please call at the Ministry of Health & Family Welfare helpline
no.: +91-11-23978046 or 1075 (Toll-free). List of helpline numbers of
States/UTs on COVID-19 is also available at
https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf.
****
MV/SG
(Release ID: 1640252) Visitor Counter : 396
Ministry of Health and Family Welfare
Sero-prevalence study conducted by National Center for
Disease Control NCDC, MoHFW, in Delhi, June 2020
Posted On: 21 JUL 2020 12:17PM by PIB Delhi
The Ministry of Health and Family Welfare [MoHFW]
commissioned a sero-surveillance study in Delhi.
This study has been done by the National Center for
Disease Control [ NCDC] in collaboration with Govt of National Capital
Territory of Delhi, following a rigorous multi-stage sampling study design.
Study was conducted from 27th of June 2020 to 10th July
2020.
For all the 11 districts of Delhi, survey teams were
formed. Blood samples were collected from selected individualsafter taking
written informed consent and then their sera were tested for IgG antibodies and
infection using COVID KAVACH ELISA approved by Indian Council for Medical
Research [ICMR]. It is one of the largest sero-prevalence studies conducted in
the country using the ELISA testing.
21,387 samples were collected as per lab standardsand
were tested. The tests done help in identification of presence of antibodies in
the general population. These test performed is not a diagnostic test but only
provides information about past infection due to SARSCoV-2 in individuals who
test positive.
Antibody testing repeatedly done over time i.e.
sero-surveillance, generates important evidence for assessing the spread of the
pandemic from time to time.
The results of the sero-prevalence study show that on an
average, across Delhi, the prevalence of IgG antibodies is 23.48 %. The
study also indicates that a large number of infected persons remain
asymptomatic. This implies the following:
1.
Nearly six
months into the epidemic, only 23.48% of the people are affectedin Delhi,which
has several pockets of dense population. This can be attributed to the
proactive efforts taken by the Government toprevent the spread of infection
including prompt lockdown,effective containment and surveillance measures, including
contact tracing and tracking, as well as citizen’s compliance to COVID
Appropriate Behaviours.
2.
However, a
significant proportion of the population is still vulnerable. Therefore, the
containment measures need to continue with the same rigour. Non-pharmacological
interventions such as physical distancing, use of face mask/cover, hand
hygiene, cough etiquette and avoidance of crowded places etc., must be followed
strictly.
****
MV
(Release ID: 1640137) Visitor Counter : 7650
No comments:
Post a Comment